New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW February 27, 2026
Risk vs. benefit: Bisphosphonates in breast cancer

Risk vs. benefit: Bisphosphonates in breast cancer

These common drugs can curb metastasis to bone and may even keep DCIS in check, but side effects make education and awareness crucial
Hutch NewsMay 04, 2021
Benefits of bisphosphonates on breast cancer outcomes

Benefits of bisphosphonates on breast cancer outcomes

From the Malone Group, Public Health Sciences Division
Science SpotlightFebruary 19, 2018